" /> Patisiran - CISMeF





Preferred Label : Patisiran;

NCIt synonyms : RNAi Therapeutic-targeting Transthyretin ALN-TTR02;

NCIt definition : A lipid nanoparticle (LNP)-based formulation consisting of small-interfering RNAs (siRNAs) directed against transthyretin (TTR) encapsulated in lipids, which has potential use in the treatment of TTR-mediated amyloidosis (ATTR). Upon intravenous administration of patisiran, the lipid formulation promotes the uptake by cells. The siRNAs bind to TTR mRNAs, which may result in the inhibition of both the translation and expression of the TTR protein. ATTR is caused by mutations in the TTR gene and results in the formation of abnormal amyloid proteins that accumulate in and cause damage to various body organs and tissues.;

UNII : 50FKX8CB2Y;

CAS number : 1420706-45-1;

Drug name : Patisiran;

Molecule name : ALN-TTR02; ALN-18328;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
05/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.